US Business

Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.

The e-commerce giant is one of the biggest U.S. employers to respond to government pressure to make overdose medicine more available in the workplace.

News Corp-controlled REA Group has made a fourth proposal to buy British peer Rightmove for roughly $8.3 billion in cash and shares, and urged its board to enter into talks.

The impact is, at best, indirect and uncertain, a finance professor argues. But there are better ways to accomplish what advocates are seeking.

The National Transportation Safety Board issued urgent recommendations for about 350 Boeing 737 jets globally.

Ireland’s data protection watchdog fined Meta Platforms after the Facebook and Instagram owner stored passwords of some social media users on its internal systems without proper safeguards.

Nike’s new leader started at the bottom of his company and made it to the very top. That might just be his biggest edge.

European pay-TV operator Sky accuses Warner of violating co-production deal giving it exclusive long-term rights to shows.

Volkswagen cut its sales and profitability forecasts for the year, joining a growing list of European rivals in lowering their targets as the industry faces an increasingly bumpy transition to electric vehicles.

The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.